Close Menu
September 08, 2020
Sponsored by
SomaLogic

What Can Proteomics Teach Us About Infectious Disease?

Partner Webinar

In this on-demand webinar, Dr. Kevin Coombs discusses six different publications describing the use of the SomaScan Assay to investigate human cellular protein alterations in tissue culture in response to Zika virus and various strains of influenza and comments on how the SomaScan Assay could be used to study COVID-19.

Sponsored by

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.

Oct
14
Sponsored by
Inivata

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

Oct
29
Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.